Purpose: Obesity is associated with changes in pulmonary function and increased systemic in ammation. We explored the relationships among adiposity, body fat distribution indices, serum in ammatory markers and pulmonary function.
Obesity is associated with an increase in the work of breathing, reduced respiratory compliance and hypoventilation, and has been considered to contribute to disorders such as sleep apnea syndrome, obesity/hyperventilation syndrome and, more recently, asthma [1] . Increased body mass index (BMI) is also associated with lung mechanical changes such as reduced functional residual capacity (FRC) and expiratory reserve volume (ERV). It has been suggested that pulmonary function could be in uenced by body fat distribution as assessed by the ratio of waist-to-hip circumferences [2, 3] ; however, waist-to-hip ratio provides only an index of relative accumulation of abdominal fat [4] . ere is a need to study the impact of abdominal fat distribution, assessed by more precise imaging techniques such as computed tomography, on pulmonary function.
Obesity is an in ammatory state. Among others, serum leptin levels, a pro-in ammatory adipokine and serum levels of TNF-α are increased in obesity [5] . Consistent with this, serum adiponectin level, an anti-in ammatory adipokine, is typically decreased in the obese subject [5] . ese hormones have been suggested to play a role in the pathogenesis of cardiovascular diseases and diabetes [6] . Plasma IL-6, C-reactive protein (CRP) and TNF-α are in ammatory factors that are also increased in obesity [7] [8] [9] . erefore, the systemic in ammation associated with obesity could contribute to the development and/or the persistence of airway in ammatory disorders such as asthma and Chronic Pulmonary Obstructive Disease (COPD) [10, 11] . e additional impact on pulmonary function of systemic in ammation, and their relationships with mechanical changes associated with obesity, remains to be determined.
e main objective of this study was to quantify the relationships among anthropometric markers of adiposity/body fat distribution and speci c variations in pulmonary function in subjects with and without a metabolic syndrome (MS or no-MS). As secondary analyses, the relationships between anthropometric markers and systemic in ammatory factors were compared and the links between markers of systemic in ammation and pulmonary function were evaluated.
Materials and Methods
is post-hoc cross-sectional analysis was conducted on a database kept in our institution that included male subjects who had previously taken part in randomized studies on obesity and for whom data on pulmonary function was available. Various markers of obesity and systemic in ammation were measured in a sub-group of this cohort, in the context of a research program on the metabolic e ects of obesity. All subjects were sedentary, doing less than 30 minutes of exercise per week, aged 18 years and over, had no known metabolic disorders or respiratory diseases and were non-smokers at the time of the enrolment. All appropriate subjects were included in the study. e studies were approved by the Ethics Committee of Laval Hospital Research Center and all subjects had signed an informed consent form.
Body mass index (BMI) was calculated from measured height and weight. Obesity, was de ned as a BMI >30 kg/m 2 , overweight >25 to <30 kg/m 2 and normal weight <25 kg/m 2 . Waist circumference (WC) was measured at the narrowest part of the torso while the subject was standing. Abdominal visceral and subcutaneous adipose tissue (AT) area were measured by computed tomography (CT) on a Siemens Somatom DRH scanner (Erlangen, Germany) as previously described [12] .
FRC was assessed with the helium dilution technique of Meneely and Kaltreider [13] . ERV was calculated by subtracting VC from FRC. Residual volume (RV) was obtained in subtracting ERV from FRC. Pulmonary volumes were expressed as percentage of predicted values. Predicted values were calculated using reference values of the European Respiratory Society [14] .
Blood samples were obtained in the morning a er a 12h overnight fast. Fasting plasma leptin and adiponectin concentrations were determined by an enzyme-linked immunosorbent assay (ELISA) (B-Bridge International, Inc., San Jose, CA, USA) on whole plasma kept at -80°C until use. Fasting plasma tumor necrosis factor alpha (TNF-α) concentrations were also assessed on deeply frozen plasma samples (80°C) and were measured by a high sensitivity ELISA for human TNF-α (R&D Systems Inc, Minneapolis, USA). Serum IL-6 levels were measured using a human IL-6 Elisa kit (R&D Systems Inc, MN, USA). High sensitive-CRP (hs-CRP) was assessed using a highly sensitive immunoassay (hs-CRP) that uses a monoclonal antibody coated to polystyrene particles performed on the Behring BN-Prospect nephelometer (Dade Behring) according to methods described by the manufacturer [15] .
e criteria used to de ne metabolic syndrome (MS) were those of the Diabetes International Federation; that is to have at least three of the ve following risk factors: high fasting plasma glucose (>5.6 mmol/L), high blood pressure (≥ 130/85 mmHg), increased waist circumference (≥ 102 cm), increased triglycerides (≥ 1.7 mmol/L) and reduced HDL-cholesterol (≤ 1.0 mmol/l) [16] .
Variables were expressed using mean ± standard deviation. Relationships between variables were measured using univariate linear regression analyses. To take into account possible confounding factors, such as BMI, WC and AT, adjusted corre-
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Results
Two hundred eighty two men were included in the analysis. A total of 124 subjects responded to the criteria of a MS while the other 158 had no-MS, with fewer than three metabolic risk factors. Many subjects had measures of systemic in ammatory factors such as leptin (n = 132), adiponectin (n = 267), TNF-α (n = 228), IL-6 (n = 228), hs-CRP (n = 91) and white blood cell (WBC) count (n = 205). e subjects' characteristics are summarized in Table 1 . BMI distribution is presented in Figure 1 .
Among the MS and no-MS subjects, mean percent of predicted ERV was, respectively, 85 ± 47 and 96 ± 33 (p = 0.02), mean percent of predicted values were, respectively, 90 ± 20 and 91 ± 17 (p = 0.60) for RV, 98 ± 11 and 101 ± 12 (p = 0.009) for VC, and 79 ± 16 and 96 ± 21 (p < 0.0001) for FRC. Correlations between anthropometric measurements and speci c variations in pulmonary function are presented in Table 2. Brie y, in subjects with a MS, decreased percent of predicted ERV and RV were signi cantly associated with an increased BMI, WC, visceral and subcutaneous AT. Decreased percent of predicted VC was only slightly but signi cantly correlated with visceral and subcutaneous AT although not with BMI and WC. ere were no signi cant correlations between anthropometric measurements and percent of predicted ERV, RV or VC in subjects with no-MS.
Mean values for measured in ammatory markers are given in Table 3 for subjects with or without MS. Leptin, adiponeptin and hs-CRP levels and WBC counts were signi cantly higher in subjects with MS than in those with no-MS. Among the subjects with a MS who had systemic in ammatory marker measurements, leptin was signi cantly correlated with BMI, WC, and subcutaneous AT while adiponectin, Il-6 and TNF-α were not signi cantly correlated with any of the anthropometric markers. Hs-CRP was signi cantly correlated with WC and Lessard et al. Obesity and pulmonary function © 2011 CIM Clin In E66 (Table 4 ). In subjects without MS, leptin was strongly correlated with increased BMI, WC, visceral and subcutaneous AT, adiponectin was signi cantly correlated with WC, visceral AT and also slightly with subcutaneous AT. IL-6, hs-CRP and WBC were signi cantly but slightly correlated with BMI and subcutaneous AT, hs-CRP and WBC were also slightly correlated with WC and nally, WBC was slightly correlated with visceral AT (Table 4) . Finally, when adjusted for BMI, WC, visceral and subcutaneous AT, neither ERV, neither RV nor VC were correlated with leptin, adiponectin, TNF-α or hs-CRP in either subjects with MS or without MS (Table 5) . No signi cant correlations were found between IL-6 or WBC and ERV, RV or VC in subjects with MS. A weak correlation was found in subjects with no-MS between VC and IL-6 and between VC and WBC.
Discussion
We found that ERV, RV and leptin levels are signi cantly associated with anthropometric measures in subjects with MS while there are no signi cant associations among ERV, RV or VC and anthropometric measures subjects without MS. Furthermore, leptin and adiponectin levels are signi cantly correlated with anthropometric measures in subjects with no MS. Markers of systemic in ammation were not signi cantly associated with changes in ERV, RV and VC a er adjustment for anthropometric characteristics except for a weak correlation of IL-6 and WBC with changes in VC in subjects with no-MS.
Our study suggests that the obesity phenotype, in terms of fat distribution, should be taken into consideration when evaluating the impact of obesity on pulmonary function. As already reported, increased BMI is associated with a reduction in ERV o en without change in RV [1] . In agreement with recent data from Babb correlations among markers of abdominal obesity and ERV were similar to those with BMI, suggesting that global obesity rather than abdominal obesity is associated with breathing near the closing volume [17] ; however, a di erent conclusion was reached for VC. While a study by Ray et al. showed no change in VC among 43 healthy non-smoking obese subjects [18] , VC was reduced to 75% of the predicted value in 43 morbidly obese subjects [19] . In our study, the correlation was signi cant with visceral and subcutaneous AT in subjects with MS, suggesting that body fat distribution may particularly in uence VC in this group. Since ERV seems to be in uenced by BMI and not only abdominal obesity, these results suggest an impact of abdominal obesity on inspiratory capacity. It has been suggested that decreased inspiratory capacity in obese subjects may result in impaired inspiratory muscle activity during exercise [20] and in reduction of the bronchoprotection of deep inspiration during induced bronchoconstriction [21] . e impact of body mass distribution on inspiratory capacity and its link to dyspnea and respiratory diseases such asthma in obese subjects needs to be further explored.
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Clin In E68 VC: vital capacity; ; TNF: tumor necr crosis alpha; Hs-CR RP: high-sensitive e C-reactive proAs already reported in other studies, serum levels of adiponectin seemed to be in uenced by the body mass distribution. In agreement with Staiger et al. [5] , adiponectin levels were found to be predominantly related to the visceral fat compartment while serum leptin levels were associated with overall obesity as estimated by the BMI. Since adipokines have been proposed to play a role in the physiopathology of respiratory diseases in obese subjects [10, 11] , these results reiterate the importance of considering body fat distribution when assessing pulmonary function in obese subjects.
Finally, there were no signi cant association between most of the systemic in ammatory markers classically associated with obesity and pulmonary function changes, suggesting that the impact of obesity on pulmonary function is mainly mediated by mechanical factors. Little is known about the e ect of systemic in ammation markers on pulmonary function among subjects without known respiratory disease and this study provides additional data on this topic.
is study has some limitations, being a retrospective analysis performed only on data from male subjects with markers of in ammation assessed only in sub-groups of subjects. Nevertheless, highly signi cant results were obtained, shedding more light on the combined e ects of mechanical and in ammatory markers on pulmonary function of the obese subject. Our study is also limited to lung volumes and the effects of the factors evaluated on airway obstruction could not be evaluated. Such analysis should be performed in subjects with airway in ammatory diseases to determine if similar associations would be observed. Sutherland et al. recently suggested that systemic in ammation does not signi cantly in uence airway in ammation in obese asthmatic subjects, although this issue will require more extensive evaluation [22] . Watz et al. showed that about half of the patients with chronic bronchitis and COPD had a co-existing metabolic syndrome associated with increased level of hs-CRP and IL-6 independent of lung function impairment [23] . An inverse relationship has also been shown between CRP concentrations and measures of pulmonary function (FEV1, FVC and PEF) in subjects without pulmonary diseases and in non-smokers [24] . Kony et al. found that in adults, increased CRP levels were strongly and independently associated with FEV 1 and FVC impairment and more frequent bronchial hyperresponsiveness [25] and that both female gender and CRP levels were signi cantly associated with airway hyperresponsiveness. Our study included men only and di erent lung volumes were evaluated; these differences could explain some apparent discrepancies between the results. Rasmussen et al. showed that in young men, higher levels of CRP at age 20 years predicted the decline in lung function by age 39 years [26] ; however, other studies either on young or older adults did not demonstrate that CRP levels predicted a subsequent decline in lung function [27, 28] .
It is possible that lung function could be altered by other obesity-associated features such as the metabolic syndrome. In our study, a signi cant inverse correlation was found between lung function measures (ERV and RV) and BMI, WC, visceral and subcutaneous tissue only in the group of subject with metabolic syndrome. Indeed, this last syndrome, usually characterized by abdominal obesity, hyperglycemia, hyperinsulinemia, dyslipidemia, and high arterial blood pressure, has been associated with an increased risk of coronary heart disease in middle-aged subjects but also to a reduction in pulmonary function [29] . In this regard, Leone et al. reported that lung function impairment was associated with metabolic syndrome independently of age, sex, smoking status, alcohol consumption, educational level, body mass index, leisure-time physical activity and cardiovascular disease history [29] . Following factor analysis, three main elements were inversely related to lung function: low high-density lipoprotein cholesterol/high triglycerides, high fasting glycemia/high blood pressure and abdominal obesity, although this last factor was the strongest predictor of lung function impairment, for both women and men.
In conclusion, these results suggest that obesity is associated with variations in pulmonary function and increases in systemic in ammation although the obesity-related changes in lung function do not seem to be signi cantly related to systemic in ammation. 
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